Showing results (711-720 of 974) with videos related to

Sort By:
Pageof 98
Future Science OA|April 5, 2021
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based studyPellegrino Cerino, Annachiara Coppola, Palmiero Volzone, et al.
American Journal of Human Genetics|June 13, 2025
Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: A systematic review of economic evaluationsLeonardo Maria Siena, Valentina Baccolini, Marianna Riccio, et al.
American Journal of Medical Genetics. Part A|December 27, 2023
Late-onset mucopolysaccharidosis type IIIA mimicking Usher syndromeAlessandro De Falco, Marianthi Karali, Chiara Criscuolo, et al.
International Journal of Molecular Sciences|December 11, 2022
Autoimmune Neutropenia and Immune-Dysregulation in a Patient Carrying a TINF2 VariantBenedetta Chianucci, Alice Grossi, Gianluca Dell'Orso, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vectorChia-Ling Gau, Robin A Rosenblatt, Vincenzo Cerullo, et al.
Molecular Therapy. Nucleic Acids|July 10, 2025
Hepatocyte delivery of miR-34b/c reduces hepatic stellate cell activation and improves liver fibrosisPasquale Piccolo, Rosa Ferriero, Claudia Perna, et al.
European Journal of Human Genetics : EJHG|June 2, 2019
Microdeletion of pseudogene chr14.232.a affects LRFN5 expression in cells of a patient with autism spectrum disorderGerarda Cappuccio, Sergio Attanasio, Marianna Alagia, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 22, 1999
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderlyI Pierri, M Clavio, G Beltrami, et al.
Pageof 98